Stelerix Web Blog Knowledge at your Fingertips

29Mar/110

Pharma Pricing Video Analysis

If you are looking for cutting edge knowledge at your fingertips, with regards to Pharma Pricing. You should definitely check out the recent pricing analysis video I did for Nexavar. It's only a few minutes long but I really show what happens in the immediate quarters following Nexavar approval for hepatocellular carcinoma.

You can read more about pharma pricing strategy and market access here.

Posted by Jeff

14Mar/110

Greening Up

Our partner at CanadianGreenTech has provided us with more exclusive, high-quality content on Canadian renewable energy opportunities. Make sure that you head to the Renewables Portal to get this pertinent information.

The articles and interviews are written by the talented Perry Hoffman, and provide thoughtful insight into a dynamic policy environment, rife with incentive for profit. Understand how you can leverage federal programs. Analyze a competitive landscape. Explore key trends.

17Feb/110

Report Giveaway – This Week Only!!

It's a $119.00 Value, for free!! We engaged over 1500 industry professionals in India and North America.

Get a thorough picture of what it takes to win in India. Forward it to your friends and get an exclusive mini-report, packed with primary research!

You can check out the Table of Contents, and download the report here!!

Posted by Jeff

15Feb/110

KOL Engagement and Alignment.

Here's a quick excerpt from our Special Comprehensive Country Report, India. It's something we've seen addressed again and again in our follow-up interviews.  I've also thrown in a YouTube interview with Tushar Barad who talks about some of the intricacies of engaging with KOLs.

The updated report will be exclusively available for free through our great friends over at pharmaphorum. So you better get registered!

"Respondents identified active engagement of local Key Opinion Leaders as the most effective means to understand their needs. Further, this strategy provides accurate insight into actual affordability as demonstrated by purchasing power and cost of living, in addition to possible commercial strategies and their respective likelihoods. However, our research also suggested that organizations as a whole have been slow to actively engage end-users. Patience and value on the long term was also a key trend among respondents. It was evident from our results that success in India favors ongoing and long-term relationships that grow and evolve over time. While short-term profit can be made, it is clear that the initial time investment and requisite patience were rewarded many times over when focus was placed on the longer term.  A further benefit of continuous investment in “relationship capital” is the evolution of mutually business partnerships. Organizations who establish themselves effectively in India can often leverage their presence to reach other fast-growing markets in the South-Asian and Asia-Pacific region. Our experts agree that to be effective into 2020 and beyond, market leaders must invest proactively in nascent relationships, given the propensity for longer cycle time in such business partnerships. Opportunity to cut costs and drive access will exist for those who look to partner and aid, rather than exploit."

Posted by Jeff

Oh yeah, the full report will also be available for download here, but this week only!!

11Feb/110

Healthcare Cost Containment in Europe

The scenario is somewhat bleak, or at least that's what Ulf Staginnus, Head of health economics in Europe at Novartis Oncology had to say.

We'll have the whole interview up on the main site, shortly. For now, enjoy this:

Best regards,

Jeff

10Feb/110

Feature: Swami Samarth Pharmatech

We've got another interview up! Check out our exclusive feature with the owner of Mumbai-based Swami Samarth Pharmatech, Nitin Parab. He talks about what's necessary for success in

We're also hosting the web version of Nitin's upcoming event "Gateway to Europe, for Medical Devices."

We are lucky to have the partners we do.

Posted by Jeff

Posted by Jeff

9Feb/110

A New Paradigm

It can be tough to sit down and watch a 40 minute interview. People don't have time to make dinner, how are they going to have time to watch something so encompassing?

With that in mind, I've begun breaking down my work into bite-size video portions. I'll post them here, and update the pages on the main site concurrently.

In this short clip, my friend Dr. Gregory Weiss talks about a new paradigm in translational medicine and drug development, based on a comprehensive, global, or combinatorial approach. Watch and learn!

Posted by Jeff

8Feb/110

Funding Initiatives and Analytical Applications.

As promised, here is the full summary and video transcript of my recent interview with Dr. Gregory Weiss.

Feel free to submit follow-up questions or start a discussion.

If you want to contribute to an upcoming interview or suggest someone as a candidate because of interesting thought-leading work, please contact us or leave a comment here!

Posted by Jeff

8Feb/110

Trends in Translational Research.

Gregory Weiss was kind enough to take a few moments out of his Saturday morning to fill me in on some of the ground-breaking research he is doing at his UCI lab.

This particular clip is about his upcoming keynote remark at the Cambridge Health Institute conference, Therapeutic Approaches to Cancer Therapeutics. I will have the whole interview up soon. But for now, enjoy this!

Posted by Jeff

2Feb/110

Health Biz India

I was lucky to get a great picture of the rapidly growing healthcare scene in India in my recent correspondence with Jayata Sharma, the Editor-in-Chief of Health Biz India.

As we've seen mentioned before, it was emphasized again that key opinion leaders are absolutely critical to progress and understanding of market conditions within India.

Inform yourself about Indian healthcare's first B2B news portal. Read this interview.

Page 1 of 212